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Providing a conceptual framework for HIV prevention 
cascades and assessing feasibility of empirical measurement 
with data from east Zimbabwe: a case study
Geoﬀ rey P Garnett, Timothy B Hallett, Albert Takaruza, James Hargreaves, Rebecca Rhead, Mitchel Warren, Constance Nyamukapa, Simon Gregson
Summary
Background The HIV treatment cascade illustrates the steps required for successful treatment and is a powerful advocacy 
and monitoring tool. Similar cascades for people susceptible to infection could improve HIV prevention programming. 
We aim to show the feasibility of using cascade models to monitor prevention programmes.
Methods Conceptual prevention cascades are described taking intervention-centric and client-centric perspectives to look 
at supply, demand, and eﬃ  cacy of interventions. Data from two rounds of a population-based study in east Zimbabwe are 
used to derive the values of steps for cascades for voluntary medical male circumcision (VMMC) and for partner reduction 
or condom use driven by HIV testing and counselling (HTC). 
Findings In 2009 to 2011 the availability of circumcision services was negligible, but by 2012 to 2013 about a third of the 
population had access. However, where it was available only 12% of eligible men sought to be circumcised leading to an 
increase in circumcision prevalence from 3·1% to 6·9%. Of uninfected men, 85·3% did not perceive themselves to be at 
risk of acquiring HIV. The proportions of men and women tested for HIV increased from 27·5% to 56·6% and from 
61·1% to 79·6%, respectively, with 30·4% of men tested self-reporting reduced sexual partner numbers and 12·8% 
reporting increased condom use.
Interpretation Prevention cascades can be populated to inform HIV prevention programmes. In eastern Zimbabwe 
programmes need to provide greater access to circumcision services and the design and implementation of associated 
demand creation activities. Whereas, HTC services need to consider how to increase reductions in partner numbers or 
increased condom use or should not be considered as contributing to prevention services for the HIV-negative adults. 
Funding Wellcome Trust and Bill & Melinda Gates Foundation.
Copyright © Garnett et al. Open Access article distributed under the terms of CC BY.
Introduction
To halt the spread of HIV requires that eﬃ  cacious 
treatment and preventive products or behaviours are 
used by those at risk. These products or behaviours are 
the direct mechanisms through which HIV prevention 
programmes exert their eﬀ ect. Analyses of whether 
programmes are eﬀ ectively preventing HIV transmission 
from mothers to children, and whether programmes are 
eﬀ ectively treating patients with HIV, have used the 
concept of a cascade to explore the steps required to 
prevent infection or death.1–4 This approach has 
powerfully illustrated what needs to be done to suppress 
HIV viral loads in many populations and is increasingly 
being used to compare the performance of prevention of 
mother to child transmission (PMTCT) and treatment 
programmes.5,6 An HIV prevention cascade could be a 
similarly powerful approach to complement the 
treatment cascade, by deﬁ ning the diﬀ erent steps in 
successful implementation of prevention interventions, 
providing estimates of the proportions of populations 
lost at each step in implementation, demonstrating 
points at which ineﬃ  ciencies occur, and providing a 
framework for planning further actions. 
The idea of using models to describe the steps in 
controlling infectious diseases was initially developed to 
explore the eﬀ ectiveness of tuberculosis control in the 
1960s.7 Illustrating the coverage of diagnosis and 
treatment was extended to HIV, and has become 
common, although diﬀ erent approaches have been 
applied.6 The characteristics of the HIV treatment 
cascade depend upon whether data comes from health 
facilities tracking patients or from population based 
studies where all those infected with HIV can be 
included.6 The cascade also diﬀ ers according to whether 
it provides a cross-sectional view of the population at a 
particular point in time or follows cohorts longitudinally 
describing their progression over time through the 
cascade.8 The description of care9 and other HIV 
services,10 in addition to treatment in cascades, can 
change the steps included and has culminated in the 
HIV prevention, treatment, and care cascade in the 
WHO Consolidated Strategic Information Guidelines for 
HIV in the Health Sector11 and the HIV Cascade 
Framework for Key Populations.12 These cascades attempt 
to include HIV prevention, but emphasise the steps of 
diagnosis, linkage to treatment, treatment initiation, and 
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viral suppression. Often HIV testing is seen as an 
essential gateway to both HIV treatment and prevention, 
and is pivotal in the HIV prevention, treatment, and care 
cascade.11 The ambition of capturing all HIV prevention 
interventions in one cascade is challenging because 
various approaches exist that focus on either HIV 
infected or HIV uninfected people and use alternative 
products and approaches such as treatment as pre-
vention, condoms, pre-exposure prophylaxis, voluntary 
medical male circumcision (VMMC), and reduction in 
sexual partner numbers.11 To explore the steps required 
for a particular approach to prevent HIV, each inter-
vention can be separated out and described in terms of 
how it can succeed or fail in the epidemiological context 
in which it is used. This does not imply that each 
intervention should be used in isolation or that each 
provider should focus on a single intervention, rather it 
describes the steps that need attention for an intervention 
to be a worthwhile part of HIV prevention.
For cascades to be useful, in addition to a theoretically 
justiﬁ ed description of HIV treatment and prevention, 
practical sources of data need to be available with which 
to populate the cascades. In this paper, we propose a new 
conceptual framework for HIV prevention cascades and 
illustrate its application with data collected in a large-
scale general-population cohort in eastern Zimbabwe.
Methods
Conceptual framework
To be eﬀ ective, prevention products or protective 
behaviours have to be used by those who can beneﬁ t from 
them, and that use depends upon delivery, acceptance, 
and adoption by the appropriate population as well as 
adherence. The treatment cascade looks at the HIV 
infected population and the steps as they progress to viral 
suppression. An analogous client-centric prevention 
cascade could explore how those at risk of acquiring HIV 
(as a starting point) could avoid infection by perceiving 
that risk and acting on that risk by both adopting (ie, 
taking up) and adhering to an eﬃ  cacious prevention 
approach (ﬁ gure 1). An alternative would be an 
intervention-centric approach, in which programme staﬀ  
identify a priority population, make an intervention 
available, see the uptake of that product, and see that it is 
used appropriately and that it is eﬃ  cacious (ﬁ gure 1). 
These prevention cascades progress from a population at 
risk of acquiring infection over a given period of time. 
The steps show the reduction in eﬀ ect, and, as a corollary, 
the eﬀ ect that improving each step can achieve. Eﬃ  cacy, 
deﬁ ned as the according-to-protocol estimate of eﬀ ect of 
an intervention in an individual randomised controlled 
trial, is the last step in the cascade and is of limited 
importance if an intervention is not delivered, adopted, 
and adhered to. An intervention needs to be made 
available through supply of products, information, or 
procedures to the population at risk. Then the priority 
population has to take up the products, information, or 
procedures. This requirement for supply and then 
demand could be illustrated the other way round with 
demand being necessary and then limited by supply. 
Supply and demand are inextricably linked, with both 
required for eﬀ ective prevention programmes.
To describe the prevention cascades deﬁ ning the 
population at risk of acquiring infection is an important 
ﬁ rst step. Theoretically, if we could accurately identify 
those that would acquire the infection without the 
intervention, then those lost at each step would acquire 
infection and the population left after all the steps of the 
cascade would be those staying uninfected. However, we 
can only identify those with a risk of infection at the start, 
so losses would be those remaining at risk and the end 
would represent those no longer at risk. Better focus on 
Research in context
Evidence before this study
The HIV or cascade treatment cascade has become a tool to 
evaluate programme performance describing the steps required 
for those HIV infected to be successfully virally suppressed. In 
addition to its advocacy role the HIV treatment and care 
cascade can act as a guide to improving programme 
performance. The HIV treatment, prevention, and care cascade 
has started to be discussed as a comprehensive HIV cascade. 
However, to date such a cascade has yet to be fully populated 
with data. To explore the use of cascades in the HIV ﬁ eld 
PubMed was searched using the terms “HIV treatment cascade”, 
“HIV prevention cascade”, “HIV care cascade”, with last search 
on Feb 23, 2016.
Added value of this study
This study describes how HIV prevention cascades might be 
considered in theory and then proceeds to use ﬁ eld data from 
rural Zimbabwe to generate HIV prevention cascades for 
voluntary male medical circumcision and for condom use and 
partner reduction after testing and counselling. The study 
illustrates the use of prevention cascades and provides a 
template for prospective studies to develop the practical use of 
the concept further in planning, implementing, and evaluating 
HIV prevention interventions.
Implications of the available evidence
In this population in rural Zimbabwe HIV prevention 
interventions have improved but are having little impact. 
VMMC was limited by supply in 2009–11, but is increasingly 
limited by demand. HIV testing and counselling has little eﬀ ect 
because men and particularly women do not change their 
behaviour. Perception of risk is a barrier to uptake on 
interventions particularly among men.
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priority populations would imply a smaller population 
that could beneﬁ t from prevention to be included in 
programmes and a smaller number in the prevention 
cascade. The same proportional reductions in eﬀ ect size 
through lack of supply, take-up, adherence, or eﬃ  cacy 
apply to those who have a risk of acquiring infection or 
those who would actually acquire infection over a period. 
Thus, the starting for the prevention cascade could be the 
predicted incidence of infection without the intervention, 
and the probable number of infections occurring with 
the intervention would be determined by the number 
dropping out along the cascade. Risk behaviour is not 
constant so one could see the denominator at risk 
population changing over time. Acknowledging the not-
at-risk population and allowing movement from not at 
risk to at risk may be possible (ﬁ gure 1). This implies that 
individuals are removed entirely from potential risk of 
exposure; alternatively, their risk could have been 
reduced through successful use of a diﬀ erent prevention 
approach, which would mean that the population at risk 
of acquiring HIV at the start of one prevention cascade is 
a function of other prevention cascades (ﬁ gure 1).
Data sources
To explore the potential of cascades to track the 
implementation and impact of HIV prevention inter-
ventions, we used data from a general population open 
cohort HIV serosurvey done in Manicaland, eastern 
Zimbabwe, the Manicaland HIV/STD Prevention 
Project. Details of the cohort have been published 
previously.1,2,13,14 In brief, a baseline survey and ﬁ ve 
rounds of follow-up have been done in a random sample 
of between 8000 and 15 000 adults recruited in a 
prospective census in 12 sites (eight sites in round six) in 
small towns, agricultural estates, roadside settlements, 
and rural villages spread across three districts in 
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Figure 1: Generic conceptual HIV prevention cascades applied to the population who would otherwise acquire HIV or are at risk of acquiring HIV
(A) Steps to prevention taking the clients’ perspective and their perception of risk into account. (B) Steps to prevention taking the intervention perspective and whether 
there is supply of the product available. (C) Including the possibility that those at risk can move into a not at risk population and vice versa. (D) Combining two 
prevention cascades where the population at risk for the start of the second intervention is the population that remain at risk after the application of the ﬁ rst 
intervention. 
For the Manicaland HIV/STD 
Prevention Project see http://
www.manicalandhivproject.org/
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Zimbabwe’s Manicaland province. Numbers varied 
between rounds because of demographic changes in the 
underlying population and changes in the sampling 
fraction following ﬂ uctuations in funding. The data 
collected in each round included information on HIV 
infection status, sexual behaviour (collected with a 
method to reduce social desirability bias),15 and 
availability, uptake, and adherence to HIV services such 
as VMMC, HIV testing and counselling (HTC), and so 
on. HIV prevalence in the study areas declined from 
24·2% in 1998–2000 to 14·5% in 2012–13; HIV incidence 
was 0·80% in 2006–11 and 0·67% in 2009–13. 
Here, we used data from the eight sites covered in both 
of the two most recent rounds of follow-up of the 
Manicaland general population cohort study (2009–11 
and 2012–13). Eligibility was restricted to adults aged 
15–54 years who were resident in and had stayed in a 
household in the study areas for at least four nights in 
the last month. Descriptive statistics were calculated for 
uptake of each HIV prevention approach by the study 
population at each round. Intervention-centric HIV 
prevention cascades (based on local availability of 
services) and client-centric HIV prevention cascades 
(based on respondents’ perceived personal risk of 
acquiring HIV infection) were con structed for all men 
and women, separately, who reported ever having had 
sex. Further intervention and client centred HIV 
prevention cascades were constructed for those reporting 
casual sexual partners in the 3 years before each survey 
to investigate the eﬀ ect of HTC in reducing risk through 
sexual partner reduction and increased condom use. Our 
aim was to see how much impact HTC was having on 
risk behaviour and HIV incidence and test whether in its 
current form in this community it should be classed as 
an HIV prevention intervention.
Availability, risk perception, uptake, and adherence for 
each HIV prevention approach within the study 
population were measured with existing questions rather 
than questions speciﬁ cally designed to explore prevention 
cascades. Respondents were taken to have a service 
available locally when they knew that the service was 
being provided at a facility within 20 km of their 
homestead. Uptake of VMMC was measured with a 
variable derived from the question “Have you ever been 
circumcised yourself?” (coded “Yes–full”, “Yes–partial”, 
and “No”) and a question on the person performing the 
circumcision (doctor, nurse, traditional healer, tribal 
elder). Men with partial circumcisions or circumcisions 
done by traditional practitioners or tribal elders were 
treated as uncircumcised in the HIV prevention cascades 
for VMMC. Uptake of HTC was measured using the 
question “On how many diﬀ erent occasions have you had 
an HIV test in your lifetime?” and a question on collection 
of most recent test results. Variables for VMMC and HTC 
uptake in the last 3 years were also created with responses 
to questions on age at circumcision and number of HIV 
tests taken in the previous 3 years. For HTC, variables on 
adherence to sexual partner reduction and increased 
condom use were constructed from responses to the 
questions “After the HIV test, did you start having more 
or fewer sexual partners? / use condoms more or less 
than before?” We have estimates of the eﬃ  cacy of VMMC 
of 60%,16 but for partner reduction and condom use we 
have only reports about whether or not behaviour changed 
so have to assume by how much. For illustrative purposes, 
we assume a 50% reduction in risk associated with 
reducing partner numbers, which is commensurate with 
the change in risk observed in earlier studies of risk 
reduction in this population13,17 and 80% reduction 
associated with condom use reported in systematic 
reviews.18 For the client-centric HIV prevention cascades, 
perceived risk among individuals currently not infected 
was measured using the question “If you are not infected 
(currently), do you think you are in danger of getting 
infected now or in the future?”
Data analysis 
To construct intervention-centric cascades, data were 
available on the number of people reporting that a service 
was available in their area, the number who had taken up 
the service. The eﬃ  cacy of the intervention was estimated 
as described above. For circumcision adherence is not 
relevant, but for HIV testing and counselling adherence 
is represented by the proportion reporting reduced 
partner numbers or increased condom use. In the client-
centric cascade the ﬁ rst reduction was based on the 
number reporting that they did not perceive that they 
were at risk of HIV and then the next step was based on 
whether they had taken up the intervention. To normalise 
the cascades and make them comparable the cascades 
were created for 1000 individuals with proportionate 
reductions at each step based on the numbers in the 
corresponding round of the Manicaland GPCS cohort. So 
for each 1000 population the number protected was ﬁ rst 
reduced by not having the service available or not 
perceiving risk, then reduced by the number not taking 
up the service, then by the number not adhering (zero in 
the case of circumcision), and then by the number where 
there would not be eﬃ  cacy leaving the number who 
would be protected from those thousand individuals. To 
explore in more detail perceptions of risk we calculated 
age adjusted odds ratios comparing perception in risk 
between men and women and uptake in HTC as a 
function of perception of risk.
For both types of cascade, estimates of potential HIV 
incidence in the absence of a given intervention Ip were 
calculated with the formula Ip = [N / (N – e × Nc)] × Io, where 
Io and N are the observed (actual) HIV incidence and the 
sample size for the speciﬁ c populations of 15–49 year olds 
in the relevant round of the Manicaland GPCS, Nc is the 
number of individuals in the population who take up and 
adhere to the service, and e is the eﬃ  cacy of the service, 
which can be measured in the according-to-protocol 
analysis in randomised controlled trials. This estimate is 
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based on the reduction in incidence from what would 
have been the case without an intervention being the 
product of eﬀ ective coverage and eﬃ  cacy for that 
intervention. For example if observed incidence in a 
population is 1% and 400 of 1000 people have adhered to 
an intervention with 50% eﬃ  cacy then the incidence 
without the intervention would have been 1·25%. Details 
of the HIV incidence estimates observed in the 
Manicaland GPCS are given in the appendix. Conﬁ dence 
intervals were calculated for binomial outcomes using 
Stata SE12.
Role of the funding source
GPG is an employee of the Bill & Melinda Gates 
Foundation, other than this the funder of the study had 
no role in study design, data collection, data analysis, 
data interpretation, or writing of the report. The 
corresponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results
In the study sites, 3·1% (95% CI 2·5–3·7) of the 3131 men 
interviewed and not infected with HIV in 2009–11 were 
circumcised: 1·8% (1·4–2·3) had received VMMC and 
1·3% (0·9–1·7) had received traditional circumcision 
(table). VMMC coverage was somewhat higher (2·7%; 
2·0–3·6) among the 1873 men who reported having 
passed their sexual debut. 3 years later, 6·9% (5·9–8·1) 
of the 2245 men interviewed in 2012–13 had been 
circumcised: 4·1% (3·4–5·1) for VMMC and 2·8% 
(2·2–3·6) for traditional circumcision. 
HIV infections occurring because of unavailability of 
local VMMC services were reduced from 96·4% to 68·4% 
over a period of about 3 years between surveys (ﬁ gure 2). 
However, the number of infections prevented increased 
only modestly from 16·3 per 1000 to 22·8 per 1000 
(assuming an eﬃ  cacy of 60%) because of limited uptake 
(12·0%) among men who knew that VMMC services were 
locally available. In the absence of the VMMC programme, 
HIV incidence would have been 0·69% per person-year of 
 Men Women
2009–11 2012–13 2009–11 2012–13
n/N % 95% CI n/N % 95% CI n/N % 95% CI n/N % 95% CI
Male circumcision
All men  
Traditional 40/3131 1·28 (0·91–1·74) 63/2245 2·81 (2·16–3·58) ·· ·· ·· ·· ·· ··
VMMC 56/3131 1·79 (1·35–2·32) 93/2245 4·14 (3·36–5·05) ·· ·· ·· ·· ·· ··
Sexually active men
VMMC
Lifetime 51/1873 2·72 (2·03–3·56) 56/1476 3·79 (2·88–4·90) ·· ·· ·· ·· ·· ··
Past 3 years 2/1873 0·11 (0·01–0·39) 24/1476 1·63 (1·04–2·41) ·· ·· ·· ·· ·· ··
HIV testing and counselling
All respondents
Lifetime uptake 867/3154 27·5 (25·9–29·1) 1284/2270 56·6 (54·5–58·6) 2872/4703 61·1 (59·7–62·5) 2625/3297 79·6 (78·2–81·0)
Past 3 years
0 2411/3154 76·4 ·· 1114/2270 49·1 ·· 2177/4703 46·3 ·· 921/3297 27·9 ··
1 505/3154 16·0 ·· 594/2270 26·2 ·· 1359/4703 28·9 ·· 858/3297 26·0 ··
≥2 238/3154 7·6 ·· 562/2270 24·8 ·· 1167/4703 24·8 ·· 1518/3297 46·0 ··
Sexually active respondents
Lifetime 742/1888 39·3 (37·1–41·6) 1046/1474 71·0 (68·6–73·3) 2742/3793 72·3 (70·8–73·7) 2475/2773 89·3 (88·0–90·4)
Past 3 years 632/1888 33·5 (31·4–35·7) 941/1474 63·8 (61·3–66·3) 2404/3793 63·4 (61·8–64·9) 2243/2773 80·9 (79·4–82·3)
Behaviour change after HTC*
Number of sexual partners
More 6/563 1·1 ·· 15/875 1·7 ·· 6/2198 0·3 ·· 9/2141 0·4 ··
Same 372/563 6·1 ·· 594/875 67·9 ·· 2080/2198 94·6 ·· 2057/2141 96·1 ··
Fewer 185/563 32·9 ·· 266/875 30·4 ·· 112/2198 5·1 ·· 75/2141 3·5 ··
Condom use   
More 79/563 14·0 ·· 112/874 12·8 ·· 90/2199 4·1 ·· 86/2143 4·0 ··
Same 420/563 74·6 ·· 637/874 72·9 ·· 2011/2199 91·5 ·· 1965/2143 91·7 ··
Fewer 64/563 11·4 ·· 125/874 14·3 ·· 98/2199 4·5 ·· 92/2143 4·3 ··
Data given for those who provided responses on the questionnaire, so diﬀ er from total sample size owing to missing data. *HIV testing and counselling in the last 3 years. VMMC=voluntary medical male 
circumcision. HTC=HIV testing and counselling.
Table: Uptake of voluntary medical male circumcision and HIV testing and counselling in HIV-uninfected adults aged 15–54 years in Manicaland, Zimbabwe
See Online for appendix
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exposure compared to 0·67% rate observed between 2009 
and 2013 in the GPCS, a reduction of just 0·02%. 
The client-centric HIV prevention cascade for 2012–13 
(ﬁ gure 2) shows that 85·3% (1876 of 2199) of uninfected 
men in Manicaland did not perceive a personal risk of 
HIV infection. However, even in those who did believe 
themselves to be at risk, uptake of VMMC services was 
just 4·0% (13 of 323). In 2009–11, 27% of men (867 of 
3154) and 57% of women (1284 of 2270) reported ever 
having had an HIV test, these proportions increased to 
61% (2872 of 4703) and 80% (2625 of 3297) in 2012–13 
(table). In 2009–11, lack of known availability and, 
particularly, lack of uptake when services were known to 
be available, were the principal obstacles to HTC having 
a major eﬀ ect in preventing HIV infections (ﬁ gure 3). 
Both of these obstacles were reduced substantially by 
2012–13, at which point, the main obstacle was lack of 
partner reduction among men who took up HTC (table). 
In 2009–11, HTC, by bringing about reductions in 
numbers of sexual partners, prevented 49 per 
1000 infec tions and reduced HIV incidence from 0·99% 
(in the absence of the programme) to 0·94% per person-
year. In 2012–13, the HIV prevention eﬀ ect of the HTC 
programme almost doubled to 90 per 1000 infections, 
and HIV incidence was reduced from 0·74% to 0·67%.
Much of the failure to prevent HIV infections resulting 
from lack of partner reduction stems from the presence 
of men who report abstinence or monogamy before 
taking up HTC in the population at risk. Restricting the 
analysis for 2009–11 to men with one or more casual 
sexual partners in the previous 3 years, reported 
availability and uptake of HTC were unchanged, but 
fewer men reported lack of partner reduction (145 per 
1000 compared with 200 per 1000; appendix p 7). Given 
their higher rate of new infections, this yielded a 
somewhat greater absolute reduction in HIV incidence 
in this group from 1·58% to 1·45%. 
For women, availability of HTC services and uptake 
when services were known were higher than for men, 
but availability and particularly uptake were still 
problematic in 2009–11 (ﬁ gure 3). Lack of uptake 
remained a limiting factor in 2012–13 (ﬁ gure 3) but the 
main obstacle in HTC contributing to reductions in HIV 
risk for women in both rounds was lack of partner 
reduction (table). Even more so than for men, this reﬂ ects 
large numbers of sexually experienced women who 
reported abstinence or monogamy prior to taking up 
HTC and conceal the greater prevention eﬀ ect in women 
with casual partners (appendix p 8). However, overall, the 
eﬀ ect of HTC in reducing numbers of sexual partners 
only reduced HIV incidence from 0·80% to 0·79% in the 
general population in the 3 year period to 2012–13.
The contributions of lack of availability and lack of 
uptake of HTC for condom use (ﬁ gure 4) are the same as 
for reducing numbers of sexual partners. Fewer men 
report increasing condom use after HTC than report 
reduced sexual partners (appendix p 4; table 1), which 
oﬀ sets the smaller (assumed) lack of eﬃ  cacy of condom 
use (20% vs 50%; ﬁ gure 4). For example, in 2012–13, the 
eﬀ ect of HTC in reducing HIV risk in sexually 
experienced men by increasing condom use was 61 per 
1000 (appendix p 13) compared to 90 per 1000 (appendix 
p 9) achieved by reducing sexual partners.
For women, lack of condom use after HTC, once again, 
was the main factor contributing to the very small eﬀ ect of 
HTC in preventing HIV infections in those otherwise at 
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Figure 2: HIV prevention cascades for voluntary medical male circumcision in 
sexually experienced uninfected men aged 15–54 years in Manicaland, 
Zimbabwe 
(A) Cascade based on service availability for 1888 individuals in 2009–11. 
(B) Cascade based on service availability for 1476 individuals in 2012–13. 
(C) Cascade based on participant’s perception of personal risk of acquiring HIV 
infection for 1476 individuals in 2012–13.
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risk (ﬁ gure 4). However, for women, increased condom 
use after HTC had a slightly larger eﬀ ect in prevention of 
HIV infections (24 per 1000 in round six) than in reductions 
in numbers of sexual partners (13 per 1000).
In the client-centric HIV prevention cascades for 
2012–13, 15·3%, of sexually active men (223 of 1457) and 
36·8% (1000 of 2717) women perceived a risk of HIV 
infection (p<0·0001; ﬁ gure 3). 124 (55·6%) of 223 men 
who felt at risk had taken up HTC compared with 805 
(65·2%) of 1234 men who did not (age-adjusted odds 
ratio 0·66; p=0·005). By contrast, 846 (84·6%) of 1000 women 
who felt at risk used HTC compared with 1359 (79·1%) of 
1717 women who did not feel at risk (1·34; p=0·007). 
Among those who felt at risk and had taken up HTC, 
43·7% of men (49 of 112) and 2·6% of women (21 of 814), 
had subsequently reduced their number of sexual 
partners; and 23·2% (26 of 112) and 4·4% (36 of 815) 
reported an increase in condom use (ﬁ gure 3). 
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Figure 3: HIV prevention cascades for HIV testing and counselling and sexual partner reduction in sexually experienced uninfected adults aged 15–54 years in 
Manicaland, Zimbabwe 
(A) Cascade for 1888 men based on service availability in 2009–11. (B) Cascade for 1468 men based on service availability in 2012–13. (C) Cascade for 3793 women 
based on service availability in 2009–11. (D) Cascade for 2743 women based on service availability in 2012–13. (E) Cascade for 1468 men based on participant’s 
perception of personal risk of acquiring HIV infection in 2012–13. (F) Cascade for 2743 women based on participant’s perception of personal risk of acquiring HIV 
infection in 2012–13.
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Discussion
In this population before 2011, circumcision was not 
widely available. By 2013, availability had improved 
somewhat but uptake was still low. In addition to low 
availability, men at risk did not perceive that risk; even 
among those who acknowledged a risk, uptake of 
circumcision was low. Over the past 2 years, circumcision 
has become more readily available in Zimbabwe and 
barriers to uptake are being addressed.19 However, in the 
rural populations studied here, acknowledgment and 
perception of risk of HIV is a substantial challenge, 
which has many potential causes.20
Analysis of HIV prevention cascades can help identify 
the barriers to eﬀ ective HIV prevention in populations, 
which is illustrated by applying diﬀ erent formulations of 
prevention cascades to data from a population at high 
risk of HIV acquisition in rural Zimbabwe. This 
application of the concept for prevention interventions 
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Figure 4: HIV prevention cascades for HIV testing and counselling and increased condom use in sexually experienced uninfected adults aged 15–54 years in 
Manicaland, Zimbabwe 
(A) Cascade for 1888 men based on service availability in 2009–11. (B) Cascade for 1468 men based on service availability in 2012–13. (C) Cascade for 3793 women 
based on service availability in 2009–11. (D) Cascade for 2743 women based on service availability in 2012–13. (E) Cascade for 1468 men based on participant’s 
perception of personal risk of acquiring HIV infection in 2012–13. (F) Cascade for 2743 women based on participant’s perception of personal risk of acquiring HIV 
infection in 2012–13. 
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used by susceptible individuals highlights the lack of 
prevention service delivery, low perceptions of risk, and 
poor uptake of HIV prevention in rural Zimbabwe. 
VMMC, condom use, and reduced partner numbers after 
HTC would be eﬃ  cacious ways of reducing HIV risk, but 
they are not widely used in Manicaland. 
HIV testing and counselling is often described as a 
gateway to both HIV treatment and HIV prevention and 
included in HIV prevention budgets, but without 
associated changes in behaviour it will not reduce HIV 
risk. Our analysis shows that, in rural eastern Zimbabwe, 
HIV testing has little eﬀ ect as HIV prevention among 
susceptible people. This is in line with some previous 
studies of the impact of HIV testing and counselling, 
which does not change the risk behaviour of HIV-
negative people.21,22 Over time, the supply and uptake of 
HTC has improved in both men and women, but the lack 
of change in partner numbers and condom use associated 
with HTC undermines its prevention eﬀ ect. This is 
particularly notable for women. In such circumstances, 
inclusion of HTC as an HIV prevention inter vention 
may not be justiﬁ able.
In applying prevention cascades to data, limitations 
arose from relying on self-reported data on availability 
including distances to services, uptake of services, and 
sexual behaviour. Cross-sectional approaches to measuring 
steps in HIV prevention cascades, as used here, can also be 
problematic. For example, cross-sec tional measurements 
of perceived risk can be unreliable since perceived risk can 
lead to VMMC uptake which, in turn, reduces perceived 
risk, generating higher VMMC in those with no perceived 
risk. Furthermore the perception of risk, actual risk, 
duration of risk, and duration of protection provided by an 
intervention need to be considered when thinking about 
how to generate a cascade where perception of risk is 
included. More consideration of such issues will be 
required when prospectively collecting data to populate 
prevention cascades.
The data analysed here were not collected with 
prevention cascade analyses in mind. Other studies 
could more explicitly include questions relating to each 
step on the cascades. Prevention cascades are most 
useful when applied to the underlying population at risk 
(ie, using population based surveys) rather than those 
adopting services, since the latter only capture those 
already taking up services. For planners looking to 
organise eﬀ ective HIV prevention this population-level 
view can come from surveys such as the current HIV 
Impact Assessments.23 However, implementers can still 
consider in their monitoring and assessment plans the 
steps of the cascade that they need to improve for their 
interventions to have eﬀ ect.
There is no one correct approach to studying HIV 
prevention cascades, although, for comparability, some 
agreement on approach would be worthwhile. However, 
to our knowledge this is the ﬁ rst time that HIV prevention 
cascades have included data. Other approaches need to 
be similarly tested with data to assess their utility. In our 
opinion, it is only by breaking out separate prevention 
interventions that the prevention cascade can be 
practically applied, as done here. There are ﬁ ve major 
limitations to the cascades. First, they only explore 
reductions in risk of acquiring HIV, not in transmitting 
HIV, so do not illustrate the importance and role of 
reduced transmissibility among people with HIV, the 
impact of which can be assessed with the treatment 
cascade. Second, they quantify the direct protection 
provided to susceptible individuals but not the onward 
protection provided when that individual does not 
acquire infection; thus they do not quantify the full eﬀ ect 
of an intervention but only a minimum level of 
protection. Third, they do not show the combined 
protection provided by two or more protection measures. 
Fourth, they are based on understanding who is at risk of 
acquiring HIV infection, which can only be inferred 
from epidemiological data. Generating useful HIV 
prevention cascades requires a good understanding of 
patterns of risk of HIV within populations. Fifth, the 
casades explore the eﬀ ect of the interventions only for 
those at risk at the time of the study not for those who 
could enter the at-risk population in the future and the 
potential of interventions to change their future 
behaviours. Potentially, combining cascades in trans-
mission dynamic models could extend our understanding 
of the impact of our interventions.  
The cascades shown here average risk over the adult 
population and look at the eﬀ ects of prevention 
interventions in the time period when the data are 
collected. Additional insights could be gained by 
disaggregating the analysis of risk by age (see appendices) 
or cohort and looking at the age and cohort speciﬁ c 
eﬀ ects of interventions.
In considering the error in measuring cascades, 
conﬁ dence intervals for each step should be based on the 
binomial distribution as people either do or do not 
continue to the next step in the cascade. The cascade is a 
measure of the potential that interventions can have to 
reduce HIV acquisition and can act as priors in a 
Bayesian model of the eﬀ ects of interventions on a 
population.
The importance of advocacy and monitoring of an HIV 
prevention cascade has been recognised for some time, 
but previous attempts have struggled to generate a single 
prevention cascade covering HIV positive and negative 
people with multiple prevention approaches. Our 
concept has been to break down HIV prevention 
according to both population and prevention approach, 
so that the important steps can be highlighted and where 
there are gaps they can be recognised. We can now start 
to develop an understanding of the more speciﬁ c 
problems and what approaches might enable better 
supply, demand, adherence, or eﬃ  cacy. This is not to say 
that delivery of HIV prevention interventions should be 
siloed as multiple approaches may be necessary and 
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should be combined where this is most eﬃ  cient. 
However, it does emphasis the requirements for each 
approach to have an impact. To illustrate this we have 
been able to generate HIV prevention cascades for 
populations in rural Zimbabwe, which illustrate just how 
far we are from eﬀ ective HIV prevention targeted at 
susceptible populations and the scale of the challenges to 
overcome. 
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